Comparative effect of tacrolimus 0.1% ointment and clobetasol 0.05% ointment in patients with oral lichen planus
- 4 February 2008
- journal article
- research article
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 35 (3) , 244-249
Abstract
Background: Oral lichen planus (OLP) is considered to be an autoimmune disease of unknown aetiology that affects the mucosae, especially the oral cavity.Objective: We compared tacrolimus 0.1% ointment and clobetasol 0.05% ointment for the treatment of OLP.Patients and Methods: A total of 32 patients (20 females and 12 males; all white, Italian origin, mean age of 43.6±18.4 years; 16 patients per treatment group) were treated with tacrolimus or clobetasol ointment for 4 weeks in a randomized, double‐blind, clinical trial. Pain severity, burning sensation, and mucosal lesion extension were assessed using a four‐point scale.Results: At the end of the treatment period, symptom scores were significantly lower in the tacrolimus group than in the clobetasol group.Conclusion: The results of this study suggest that tacrolimus 0.1% ointment is more effective than clobetasol propionate 0.05% ointment in the treatment of OLP. However, other studies are needed to confirm the effectiveness of this treatment before it can be recommended for use in clinical practice.Keywords
This publication has 22 references indexed in Scilit:
- Comparison of topical tacrolimus 0.1 % in pectin ointment with clobetasol 0.5% ointment in adults with moderate to severe desquamative gingivitis: A 4-week, randomized, double-blind clinical trialClinical Therapeutics, 2006
- A Comparison of Treatment of Oral Lichen Planus with Topical Tacrolimus and Triamcinolone Acetonide OintmentActa Dermato-Venereologica, 2006
- Successful treatment of severe recalcitrant erosive oral lichen planus with topical tacrolimusJournal of the European Academy of Dermatology and Venereology, 2005
- Ciclosporin vs. clobetasol in the topical management of atrophic and erosive oral lichen planus: a double-blind, randomized controlled trialBritish Journal of Dermatology, 2005
- Oral lichen planus: an overviewJournal of Dermatological Treatment, 2004
- A new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic/erosive oral lichen planus. A Phase IV, randomized, observer-blinded, parallel group clinical trialBritish Journal of Dermatology, 2004
- Oral Lichen Planus Part I: Epidemiology, Clinics, Etiology, Immunopathogeny, and DiagnosisSKINmed: Dermatology for the Clinician, 2003
- Drug interactions—fact or fiction?Clinics in Dermatology, 2003
- Severe oral lichen planus: remission and maintenance with Vitamin A analoguesJournal of Oral Pathology & Medicine, 1983
- Statistics and ethics in medical research: III How large a sample?BMJ, 1980